The nociceptin/orphanin FQ system as a target for treating alcoholism

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 1, 2010, Pages 87-93

  Murphy, Niall P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Addiction; Alcohol; Alcoholism; Nociceptin; Opioids; Orphanin FQ

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; ALCOHOL; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; NPHE; UFP 101; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; BEHAVIOR; DRUG TARGETING; MOUSE; NONHUMAN; REVIEW;

EID: 77949895121     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710790966713     Document Type: Review

References (77)

1. Meunier, J.C.; Mollereau, C.; Toll, L.; Suaudeau, C.; Moisand, C.; Alvinerie, P.; Butour, J.L.; Guillemot, J.C.; Ferrara, P.; Monsarrat, B.; Mazaguill, H.; Vassart, G.; Parmentier, M.; Costentin, J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 1995, 377, 532-535.
2. Reinscheid, R.K.; Nothacker, H.P.; Bourson, A.; Ardati, A.; Henningsen, R.A.; Bunzow, J.R.; Grandy, D.K.; Langen, H.; Monsma, F.J., Jr.; Civelli, O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 1995, 270, 792-794.
3. Civelli, O. The orphanin FQ/nociceptin (OFQ/N) system. Results Probl. Cell Differ., 2008, 46, 1-25.
4. Chiou, L.C.; Liao, Y.Y.; Fan, P.C.; Kuo, P.H.; Wang, C.H.; Riemer, C.; Prinssen, E.P. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr. Drug Targets, 2007, 8, 117-135.
5. Neal, C.R., Jr.; Mansour, A.; Reinscheid, R.; Nothacker, H.P.; Civelli, O.; Watson, S.J., Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol., 1999, 406, 503-547.
6. Neal, C.R., Jr.; Mansour, A.; Reinscheid, R.; Nothacker, H.P.; Civelli, O.; Akil, H.; Watson, S.J., Jr. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol., 1999, 412, 563-605.
7. Olszewski, P.K.; Levine, A.S. Minireview: Characterization of influence of central nociceptin/orphanin FQ on consummatory behavior. Endocrinology, 2004, 145, 2627-2632.
8. Blakley, G.G.; Pohorecky, L.A.; Benjamin, D. Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor. Psychopharmacology (Berl), 2004, 171, 421-428.
9. Uezu, K.; Sei, H.; Sano, A.; Toida, K.; Suzuki-Yamamoto, T.; Houtani, T.; Sugimoto, T.; Takeshima, H.; Ishimura, K.; Morita, Y. Lack of nociceptin receptor alters body temperature during resting period in mice. Neuroreport, 2004, 15, 751-755.
10. Sinchak, K.; Hendricks, D.G.; Baroudi, R.; Micevych, P.E. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. Neuroreport, 1997, 8, 3857-3860.
11. Ikeda, K.; Watanabe, M.; Ichikawa, T.; Kobayashi, T.; Yano, R.; Kumanishi, T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol., 1998, 399, 139-151.
12. Fornari, R.V.; Soares, J.C.; Ferreira, T.L.; Moreira, K.M.; Oliveira, M.G. Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behav. Neurosci., 2008, 122, 98-106.
13. Gavioli, E.C.; Calo, G. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Arch. Pharmacol., 2006, 372, 319-330.
14. Green, M.K.; Devine, D.P. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress. Neuropeptides, 2009, 43(6), 50-514.
15. Mollereau, C.; Simons, M.J.; Soularue, P.; Liners, F.; Vassart, G.; Meunier, J.C.; Parmentier, M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. USA, 1996, 93, 8666-8670.
16. Koizumi, M.; Midorikawa, N.; Takeshima, H.; Murphy, N.P. Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice. J. Neurochem., 2004, 89, 257-263.
17. Ciccocioppo, R.; Polidori, C.; Antonelli, L.; Salvadori, S.; Guerrini, R.; Massi, M. Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides, 2002, 23, 117-125.
18. Ciccocioppo, R.; Economidou, D.; Rimondini, R.; Sommer, W.; Massi, M.; Heilig, M. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol. Psychiatry, 2007, 61, 4-12.
19. Sakoori, K.; Murphy, N.P. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses. Neuropsychopharmacology, 2008, 33, 877-891.
20. Kuzmin, A.; Sandin, J.; Terenius, L.; Ogren, S.O. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther., 2003, 304, 310-318.
21. Huang, J.; Young, B.; Pletcher, M.T.; Heilig, M.; Wahlestedt, C. Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict. Biol., 2008, 13, 88-94.
22. Xuei, X.; Flury-Wetherill, L.; Almasy, L.; Bierut, L.; Tischfield, J.; Schuckit, M.; Nurnberger, J.I., Jr.; Foroud, T.; Edenberg, H.J. Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addict. Biol., 2008, 13, 80-87.
23. Kuzmin, A.; Bazov, I.; Sheedy, D.; Garrick, T.; Harper, C.; Bakalkin, G. Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain Res., 2009, 1305, S80-S85.
24. Lindholm, S.; Ploj, K.; Franck, J.; Nylander, I. Nociceptin/orphanin FQ tissue concentration in the rat brain: effects of repeated ethanol administration at various post-treatment intervals. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26, 303-306.
25. Ploj, K.; Roman, E.; Gustavsson, L.; Nylander, I. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res. Bull., 2000, 53, 219-226.
26. Gustafsson, L.; Ploj, K.; Nylander, I. Effects of maternal separation on voluntary ethanol intake and brain peptide systems in female Wistar rats. Pharmacol. Biochem. Behav., 2005, 81, 506-516.
27. Economidou, D.; Hansson, A.C.; Weiss, F.; Terasmaa, A.; Sommer, W.H.; Cippitelli, A.; Fedeli, A.; Martin-Fardon, R.; Massi, M.; Ciccocioppo, R.; Heilig, M. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol. Psychiatry, 2008, 64, 211-218.
28. Wise, R.A.; Bozarth, M.A. A psychomotor stimulant theory of addiction. Psychol. Rev., 1987, 94, 469-492.
29. Lutfy, K.; Khaliq, I.; Carroll, F.I.; Maidment, N.T. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl), 2002, 164, 168-176.
30. Kotlinska, J.; Rafalski, P.; Biala, G.; Dylag, T.; Rolka, K.; Silberring, J. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur. J. Pharmacol., 2003, 474, 233-239.
31. Robinson, T.E.; Berridge, K.C. Review. The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2008, 363, 3137-3146.
32. Soderpalm, B.; Lof, E.; Ericson, M. Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system. Pharmacopsychiatry, 2009, 42(Suppl 1), S87-S94.
33. Wise, R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci., 2004, 5, 483-494.
34. Koizumi, M.; Sakoori, K.; Midorikawa, N.; Murphy, N.P. The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism. Br. J. Pharmacol., 2004, 143, 53-62.
35. Murphy, N.P.; Lam, H.A.; Chen, Z.; Pintar, J.E.; Maidment, N.T. Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene. Brain Res., 2002, 953, 276-280.
36. Wagner, E.J.; Ronnekleiv, O.K.; Grandy, D.K.; Kelly, M.J. The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance. Neuroendocrinology, 1998, 67, 73-82.
37. Roberto, M.; Siggins, G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. USA, 2006, 103, 9715-9720.
38. Cavallini, S.; Marino, S.; Beani, L.; Bianchi, C.; Siniscalchi, A. Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport, 2003, 14, 2167-2170.
39. Murphy, N.P.; Maidment, N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem., 1999, 73, 179-186.
40. Bruchas, M.R.; Land, B.B.; Chavkin, C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res., 2009, (in press).
41. Mollereau, C.; Roumy, M.; Zajac, J.M. Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem., 2005, 5, 341-355.
42. Ciccocioppo, R.; Panocka, I.; Polidori, C.; Regoli, D.; Massi, M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl), 1999, 141, 220-224.
43. Ciccocioppo, R.; Economidou, D.; Fedeli, A.; Angeletti, S.; Weiss, F.; Heilig, M.; Massi, M. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl), 2004, 172, 170-178.
44. Ciccocioppo, R.; Angeletti, S.; Sanna, P.P.; Weiss, F.; Massi, M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur. J. Pharmacol., 2000, 404, 153-159.
45. Devine, D.P.; Reinscheid, R.K.; Monsma, F.J., Jr.; Civelli, O.; Akil, H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res., 1996, 727, 225-229.
46. Le Pen, G.; Wichmann, J.; Moreau, J.L.; Jenck, F. The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats. Neuroreport, 2002, 13, 451-454.
47. Sakoori, K.; Murphy, N.P. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berl.), 2004, 172, 129-136.
48. Economidou, D.; Fedeli, A.; Fardon, R.M.; Weiss, F.; Massi, M.; Ciccocioppo, R. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides, 2006, 27, 3299-3306.
49. Pomonis, J.D.; Billington, C.J.; Levine, A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport, 1996, 8, 369-371.
50. Koizumi, M.; Cagniard, B.; Murphy, N.P. Endogenous nociceptin modulates diet preference independent of motivation and reward. Physiol. Behav., 2009, 97, 1-13.
51. Cifani, C.; Guerrini, R.; Massi, M.; Polidori, C. Chronic intracerebroventricular infusion of nociceptin/orphanin FQ increases food and ethanol intake in alcohol-preferring rats. Peptides, 2006, 27, 2803-2810.
52. Green, A.S.; Grahame, N.J. Ethanol drinking in rodents: is free-choice drinking related to the reinforcing effects of ethanol? Alcohol, 2008, 42, 1-11.
53. Martin-Fardon, R.; Ciccocioppo, R.; Massi, M.; Weiss, F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport, 2000, 11, 1939-1943.
54. Walker, J.R.; Spina, M.; Terenius, L.; Koob, G.F. Nociceptin fails to affect heroin self-administration in the rat. Neuroreport, 1998, 9, 2243-2247.
55. Sinha, R. The role of stress in addiction relapse. Curr. Psychiatry Rep., 2007, 9, 388-395.
56. Kuzmin, A.; Kreek, M.J.; Bakalkin, G.; Liljequist, S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology, 2007, 32, 902-910.
57. Fernandez, F.; Misilmeri, M.A.; Felger, J.C.; Devine, D.P. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology, 2004, 29, 59-71.
58. Ploj, K.; Roman, E.; Nylander, I. Effects of maternal separation on brain nociceptin/orphanin FQ peptide levels in male Wistar rats. Pharmacol. Biochem. Behav., 2002, 73, 123-129.
59. Reiss, D.; Wolter-Sutter, A.; Krezel, W.; Ouagazzal, A.M. Effects of social crowding on emotionality and expression of hippocampal nociceptin/orphanin FQ system transcripts in mice. Behav. Brain Res., 2007, 184, 167-173.
60. Uchiyama, H.; Yamaguchi, T.; Toda, A.; Hiranita, T.; Watanabe, S.; Eyanagi, R. Involvement of the GABA/benzodiazepine receptor in the axiolytic-like effect of nociceptin/orphanin FQ. Eur. J. Pharmacol., 2008, 590, 185-189.
61. Gavioli, E.C.; Duarte, F.S.; Guerrini, R.; Calo, G.; Rae, G.A.; TC, M.D.L. GABA(A) signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze. Peptides, 2008, 29, 1404-1412.
62. Gavioli, E.C.; Marzola, G.; Guerrini, R.; Bertorelli, R.; Zucchini, S.; De Lima, T.C.; Rae, G.A.; Salvadori, S.; Regoli, D.; Calo, G. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur. J. Neurosci., 2003, 17, 1987-1990.
63. Gu, H.; Hu, D.; Hong, X.R.; Mao, J.; Cui, Y.; Hui, N.; Sha, J.Y. Changes and significance of orphanin and serotonin in patients with postpartum depression. Zhonghua Fu. Chan. Ke. Za. Zhi., 2003, 38, 727-728.
64. Rodi, D.; Zucchini, S.; Simonato, M.; Cifani, C.; Massi, M.; Polidori, C. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl), 2008, 196, 523-531.
65. Ciccocioppo, R.; Martin-Fardon, R.; Weiss, F.; Massi, M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport, 2001, 12, 1145-1149.
66. Shalev, U.; Erb, S.; Shaham, Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res., 2009, (in press).
67. Mamiya, T.; Noda, Y.; Nishi, M.; Takeshima, H.; Nabeshima, T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res., 1998, 783, 236-240.
68. Lee, J.L. Reconsolidation: maintaining memory relevance. Trends Neurosci., 2009, 32, 413-420.
69. Matsumoto, M.; Hikosaka, O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature, 2009, 459, 837-841.
70. Kelley, A.E.; Berridge, K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci., 2002, 22, 3306-3311.
71. Fulton, S.; Pissios, P.; Manchon, R.P.; Stiles, L.; Frank, L.; Pothos, E.N.; Maratos-Flier, E.; Flier, J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron, 2006, 51, 811-822.
72. Aston-Jones, G.; Smith, R.J.; Moorman, D.E.; Richardson, K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology, 2009, 56(Suppl 1), 112-121.
73. Leinninger, G.M.; Jo, Y.H.; Leshan, R.L.; Louis, G.W.; Yang, H.; Barrera, J.G.; Wilson, H.; Opland, D.M.; Faouzi, M.A.; Gong, Y.; Jones, J.C.; Rhodes, C.J.; Chua, S., Jr.; Diano, S.; Horvath, T.L.; Seeley, R.J.; Becker, J.B.; Munzberg, H.; Myers, M.G., Jr. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell. Metab., 2009, 10, 89-98.
74. Matsushita, H.; Ishihara, A.; Mashiko, S.; Tanaka, T.; Kanno, T.; Iwaasa, H.; Ohta, H.; Kanatani, A. Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice. Endocrinology, 2009, 150, 2668-2673.
75. Boutrel, B. A neuropeptide-centric view of psychostimulant addiction. Br. J. Pharmacol., 2008, 154, 343-357.
76. Ciccocioppo, R.; Gehlert, D.R.; Ryabinin, A.; Kaur, S.; Cippitelli, A.; Thorsell, A.; Le, A.D.; Hipskind, P.A.; Hamdouchi, C.; Lu, J.; Hembre, E.J.; Cramer, J.; Song, M.; McKinzie, D.; Morin, M.; Economidou, D.; Stopponi, S.; Cannella, N.; Braconi, S.; Kallupi, M.; de Guglielmo, G.; Massi, M.; George, D.T.; Gilman, J.; Hersh, J.; Tauscher, J.T.; Hunt, S.P.; Hommer, D.; Heilig, M. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. Alcohol, 2009, 43, 491-498.
77. Samson, H.H.; Czachowski, C.L. Behavioral measures of alcohol self-administration and intake control: rodent models. Int. Rev. Neurobiol., 2003, 54, 107-143.